Medifast
MED
251 hedge funds and large institutions have $1.53B invested in Medifast in 2019 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 78 increasing their positions, 88 reducing their positions, and 37 closing their positions.
116% more call options, than puts
Call options by funds: $65.4M | Put options by funds: $30.2M
27% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 37
2% more funds holding
Funds holding: 246 → 251 (+5)
0% more capital invested
Capital invested by funds: $1.52B → $1.53B (+$7.06M)
2.65% less ownership
Funds ownership: 100.73% → 98.09% (-2.6%)
11% less repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 88
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
N
Nuveen
Charlotte,
North Carolina
|
+$24.3M |
| 2 |
HCM
Hoplite Capital Management
New York
|
+$20.4M |
| 3 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$14.7M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$10.3M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$8.15M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$22.2M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$21.9M |
| 3 |
JIM
Jupiter Investment Management
London,
United Kingdom
|
-$15.3M |
| 4 |
1WCM
12 West Capital Management
New York
|
-$14.7M |
| 5 |
WG
Winton Group
London,
United Kingdom
|
-$7.18M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ECM
276
Element Capital Management
New York
| – | -$233K | -1,823 | Closed |
|
277
Creative Planning
Overland Park,
Kansas
| – | -$227K | -1,783 | Closed |
|
|
BLA
278
Balter Liquid Alternatives
Boston,
Massachusetts
| – | -$191K | -1,500 | Closed |
|
279
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | -$39K | -305 | Closed |
|
|
SWM
280
SeaCrest Wealth Management
Purchase,
New York
| – | -$19K | -150 | Closed |
|
|
CCM
281
Cribstone Capital Management
Augusta,
Maine
| – | -$13K | -100 | Closed |
|
|
PCM
282
Prelude Capital Management
New York
| – | -$13K | -100 | Closed |
|
|
PHK
283
Point72 Hong Kong
Hong Kong
| – | -$7K | -58 | Closed |
|
|
WAM
284
Wealthspire Advisors (Maryland)
Potomac,
Maryland
| – | -$7K | -53 | Closed |
|
|
CAM
285
Cresset Asset Management
Chicago,
Illinois
| – | -$3K | -25 | Closed |
|
|
VCM
286
Versant Capital Management
Phoenix,
Arizona
| – | -$1K | -11 | Closed |
|
|
NCM
287
Next Capital Management
New York
| – | +$139 | +1 | New |
|
|
TFO
288
Tarbox Family Office
Newport Beach,
California
| – | +$417 | +3 | New |
|
MED Hedge Fund Activity: Q2 2019 in Review
251 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q2 2019, worth a combined $1.53B — up 0.46% from $1.52B a quarter earlier.
Buyers outnumbered sellers: 47 funds opened new MED positions and 37 closed out — a net gain of 10 holders — while 78 added to existing stakes and 88 trimmed.
The largest buyer was Nuveen, adding an estimated $24.3M. The largest seller was Renaissance Technologies, cutting an estimated $22.2M.
- 251 institutional investors held Medifast (MED) as of Q2 2019, up from 246 in Q1 2019.
- Funds reported $1.53B of Medifast stock for Q2 2019, up 0.46% quarter-over-quarter.
- 47 funds opened new Medifast positions in Q2 2019 and 37 closed out, a net change of +10 holders.
- The largest Medifast buyer in Q2 2019 was Nuveen, an estimated $24.3M added.
- The largest Medifast seller in Q2 2019 was Renaissance Technologies, an estimated $22.2M sold.
Based on aggregated 13F filings for Q2 2019.